C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
Saved in:
| Title: | C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19. |
|---|---|
| Authors: | Camon, Ana M.1 (AUTHOR), Alonso, Rodrigo1 (AUTHOR), Muñoz, Francisco J.1 (AUTHOR), Cardozo, Celia1 (AUTHOR), Bernal-Maurandi, Javier1 (AUTHOR), Albiach, Laia1 (AUTHOR), Agüero, Daiana1 (AUTHOR), Marcos, M. Angeles2,3,4 (AUTHOR), Ambrosioni, Juan1 (AUTHOR), Bodro, Marta1 (AUTHOR), Chumbita, Mariana1 (AUTHOR), De la Mora, Lorena1 (AUTHOR), Garcia-Pouton, Nicole1 (AUTHOR), Dueñas, Gerard1 (AUTHOR), Hernandez-Meneses, Marta1 (AUTHOR), Inciarte, Alexy1 (AUTHOR), Cuesta, Genoveva2,3,4 (AUTHOR), Meira, Fernanda1 (AUTHOR), Morata, Laura1 (AUTHOR), Puerta-Alcalde, Pedro1 (AUTHOR) |
| Source: | Scientific Reports. 3/29/2022, Vol. 12 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
